business
Kimberly-Clark Closes Its Acquisition of Tylenol Maker Kenvue
Kimberly-Clark Closes Its Acquisition of Tylenol Maker Kenvue
Subscribe to CNBC PRO Subscribe to Investing Club Licensing & Reprints CNBC Councils Join the CNBC Panel Digital Products News Releases Closed Captioning Corrections About CNBC Internships Site Map Careers Help Contact News Tips Got a confidential news tip? We want to hear from you. Get In Touch CNBC Newsletters Sign up for free newsletters and get more CNBC delivered to your inbox Sign Up Now Get this delivered to your inbox, and more info about our products and services.
Latest updates
Kimberly-Clark Closes Its Acquisition of Tylenol Maker Kenvue
Kimberly-Clark has closed its acquisition of Kenvue, the company behind the Tylenol brand, according to CNBC. The company says it has a plan to improve growth and earnings following the deal. The reporting available does not include the transaction value or detailed synergy targets. Kenvue's consumer health products include pain relief medicines alongside other personal care brands. Investors will be watching how the combined company integrates the businesses and whether it meets its growth goals in the coming quarters.